Table 7.6c

Immunosuppression Use: Maintenance Between Discharge

and One Year Posttransplant, 1992 to 2001

Recipients with Pancreas After Kidney (PAK) Transplants

		Year of Transplant
		1992	1993	1994	1995	1996	1997	1998	1999	2000	2001
Transplants		29	61	55	67	113	130	157	222	303	307
Tx With Follow-up Immunosuppression Info		17	39	42	49	87	105	129	197	260	267
Corticosteroids	Category Usage	0.0%	41.0%	21.4%	83.7%	100.0%	100.0%	100.0%	99.5%	98.8%	98.1%
	Steroids	0.0%	41.0%	21.4%	83.7%	100.0%	100.0%	100.0%	99.5%	98.8%	98.1%
Cyclosporine	Category Usage	100.0%	100.0%	76.2%	61.2%	50.6%	21.0%	33.3%	15.7%	18.1%	14.6%
	Cyclosporin	100.0%	100.0%	76.2%	24.5%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	Sandimmmune	0.0%	2.6%	0.0%	22.4%	9.2%	4.8%	5.4%	3.6%	4.2%	0.7%
	Neoral	0.0%	0.0%	0.0%	42.9%	42.5%	19.0%	29.5%	12.7%	14.2%	12.7%
	Gengraf	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	1.2%	1.1%
	Eon	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.7%
Tacrolimus	Category Usage	0.0%	7.7%	45.2%	46.9%	63.2%	88.6%	76.0%	89.8%	89.6%	92.9%
	FK506	0.0%	7.7%	45.2%	46.9%	63.2%	88.6%	76.0%	89.8%	89.6%	92.9%
Antimetabolites	Category Usage	100.0%	100.0%	90.5%	95.9%	98.9%	96.2%	97.7%	93.4%	85.4%	80.5%
	Azathioprine	100.0%	100.0%	90.5%	65.3%	17.2%	8.6%	9.3%	7.1%	5.4%	2.6%
	Mycophenolate mofetil	0.0%	0.0%	2.4%	63.3%	88.5%	92.4%	94.6%	90.9%	83.5%	79.0%
Other	Category Usage	0.0%	0.0%	0.0%	0.0%	1.1%	0.0%	1.6%	6.6%	23.8%	28.8%
	Rapamycin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.8%	6.6%	23.8%	28.8%
	Cytoxan	0.0%	0.0%	0.0%	0.0%	1.1%	0.0%	0.8%	0.0%	0.0%	0.0%

Source: OPTN/SRTR Data as of August 1, 2003.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may

be prescribed more than one drug within the same category.